ืคื•ืกืคื˜ื™ื“ื™ืœืกืจื™ืŸ SharpPSยฎ - ื”ืžื“ืจื™ืš ื”ืžืœื ืœืžืจื›ื™ื‘ ืœื‘ืจื™ืื•ืช ื”ืžื•ื—

ืžื—ืงืจื™ื ืืœื• ืžื™ื•ื“ืขื™ื ืœืฉื™ืžื•ืฉ ืžื™ื“ืข ื‘ืœื‘ื“ ื•ืื™ื ื ืžื”ื•ื•ื™ื ืชื—ืœื™ืฃ ืœื™ื•ืขืฅ ืจืคื•ืื™.
ืื ื• ืžืกืคืงื™ื ืžื™ื“ืข ื–ื” ื›ืฉื™ืจื•ืช, ืื™ืŸ ืœื”ืžืœื™ืฅ ืื• ืœืืฉืจ ืžื•ืฆืจื™ื ืžื•ืฆืจื™ื ืขืœ ืคื™ ื–ื”.

ย 

ื”ืฆื•ืจื” ื”ืคื˜ื ื˜ื™ืช, ื”ื ื—ืงืจืช ื•ื”ืžื•ื›ื—ืช ื‘ื™ื•ืชืจ ืฉืœ ืคื•ืกืคื˜ื™ื“ื™ืœืกืจื™ืŸ - ืžื‘ื™ืช Enzymotec ื™ืฉืจืืœ

๐Ÿ‡ฎ๐Ÿ‡ฑ ืขื•ื‘ื“ื” ืฉื›ื“ืื™ ืœื“ืขืช: SharpPSยฎ ืžื™ื•ืฆืจ ืขืœ ื™ื“ื™ Enzymotecย  - ื—ื‘ืจื” ื‘ื™ื•ื˜ื›ื ื•ืœื•ื’ื™ืช ื™ืฉืจืืœื™ืช. ื”ืžื—ืงืจ, ื”ืคื™ืชื•ื— ื•ื™ื™ืฆื•ืจ ื—ืœืงื™ ื”ืžืจื›ื™ื‘ ืžืชื‘ืฆืขื™ื ื‘ื™ืฉืจืืœ.

ืžื” ื–ื” ืคื•ืกืคื˜ื™ื“ื™ืœืกืจื™ืŸ?

ืคื•ืกืคื˜ื™ื“ื™ืœืกืจื™ืŸ (Phosphatidylserine, PS) ื”ื•ื ืคื•ืกืคื•ืœื™ืคื™ื“ - ื—ื•ืžืจ ืฉื•ืžื ื™ ื”ื ืžืฆื ื‘ืื•ืคืŸ ื˜ื‘ืขื™ ื‘ืžืžื‘ืจื ื•ืช ืชืื™ ื”ืžื•ื—. ื”ื•ื ืžื”ื•ื•ื” ื›-15% ืžืกืš ื”ืคื•ืกืคื•ืœื™ืคื™ื“ื™ื ื‘ืžื•ื— ื”ืื ื•ืฉื™ ื•ืžืจื•ื›ื– ื‘ืขื™ืงืจ ื‘ื ื•ื™ืจื•ื ื™ื - ืชืื™ ื”ืขืฆื‘.

PS ืžืžืœื ืชืคืงื™ื“ ืงืจื™ื˜ื™ ื‘:

  • ืชืงืฉื•ืจืช ื‘ื™ืŸ-ืชืื™ืช ืฉืœ ื ื•ื™ืจื•ื ื™ื
  • ื”ืขื‘ืจืช ืžืกืจื™ื ืขืฆื‘ื™ื™ื (neurotransmission)
  • ืฉืžื™ืจื” ืขืœ ื’ืžื™ืฉื•ืช ืžืžื‘ืจื ื•ืช ื”ืชืื™ื
  • ื•ื™ืกื•ืช ืžื ื’ื ื•ื ื™ ืชื’ื•ื‘ื” ืœืกื˜ืจืก

ืžื” ื–ื” SharpPSยฎ ื•ืœืžื” ื–ื” ื—ืฉื•ื‘?

ืœื ื›ืœ ืคื•ืกืคื˜ื™ื“ื™ืœืกืจื™ืŸ ื ื•ืฆืจ ืฉื•ื•ื”. SharpPSยฎ ื”ื•ื ื”ืฆื•ืจื” ื”ืคื˜ื ื˜ื™ืช ืฉืคื•ืชื—ื” ืขืœ ื™ื“ื™ ื—ื‘ืจื” ื‘ื™ื•ื˜ื›ื ื•ืœื•ื’ื™ืช ื™ืฉืจืืœื™ืช ื•ืžื•ื‘ื™ืœืช ืขื•ืœื ื‘ืžืจื›ื™ื‘ื™ื ืคื•ื ืงืฆื™ื•ื ืœื™ื™ื.

ื”ื”ื‘ื“ืœ ื”ืขื™ืงืจื™:

  • ื˜ื•ื”ืจ ื’ื‘ื•ื” - ืชื”ืœื™ืš ื™ื™ืฆื•ืจ ืคื˜ื ื˜ื™ ืขื ื‘ืงืจืช ืื™ื›ื•ืช ืžื—ืžื™ืจื”
  • ืžื—ืงืจื™ื ืงืœื™ื ื™ื™ื ื™ื™ืขื•ื“ื™ื™ื - ื ื—ืงืจ ืกืคืฆื™ืคื™ืช, ืœื ืคื•ืกืคื˜ื™ื“ื™ืœืกืจื™ืŸ ื’ื ืจื™
  • ื”ื›ืจื” ืจื’ื•ืœื˜ื•ืจื™ืช - ื”ื‘ืกื™ืก ืœืžืขืžื“ Qualified Health Claim ืฉืœ ื”-FDA

ืžื” ื”ืžื—ืงืจื™ื ืื•ืžืจื™ื ืขืœ Phosphatidylserine?

๐Ÿ”ฌ ืžื—ืงืจ ืงืœื™ื ื™ ืžืจื›ื–ื™ - Crook et al., 1991 (Neurology)

ืžื—ืงืจ ื›ืคื•ืœ-ืกืžื™ื•ืช ืฉื‘ื“ืง 149 ืžืฉืชืชืคื™ื ืขื ื™ืจื™ื“ื” ืงื•ื’ื ื™ื˜ื™ื‘ื™ืช ื”ืงืฉื•ืจื” ืœื’ื™ืœ. ืงื‘ื•ืฆืช ื”ื˜ื™ืคื•ืœ ืฉื ื˜ืœื” 300 ืž"ื’ Phosphatidylserine ื™ื•ืžื™ืช ื‘ืžืฉืš 12 ืฉื‘ื•ืขื•ืช ื”ืจืืชื” ืฉื™ืคื•ืจ ืžื•ื‘ื”ืง ื‘ื–ื™ื›ืจื•ืŸ ื•ื‘ืœืžื™ื“ื” ืœืขื•ืžืช ืคืœืฆื‘ื• ื‘ืžื™ื•ื—ื“ ื‘ืงืจื‘ ืื ืฉื™ื ืขื ื™ืจื™ื“ื” ืงื•ื’ื ื™ื˜ื™ื‘ื™ืช ื‘ื•ืœื˜ืช ื™ื•ืชืจ.
PubMed PMID: 1944904

๐Ÿ”ฌ ืžื—ืงืจ ื™ืฉืจืืœื™ Vakhapova et al., 2010

ืžื—ืงืจ ื™ืฉืจืืœื™ ืฉื‘ื“ืง PS ื”ืžื•ืขืฉืจ ื‘ื—ื•ืžืฆื•ืช ืฉื•ืžืŸ ืื•ืžื’ื” 3. ื”ืžืžืฆืื™ื ื”ืจืื• ืฉื™ืคื•ืจ ื‘ื™ื›ื•ืœื•ืช ื–ื™ื›ืจื•ืŸ ื‘ืงืจื‘ ืงืฉื™ืฉื™ื ืขื ืชืœื•ื ื•ืช ืขืœ ื™ืจื™ื“ื” ืงื•ื’ื ื™ื˜ื™ื‘ื™ืชย ืœืœื ืชื•ืคืขื•ืช ืœื•ื•ืื™ ืžืฉืžืขื•ืชื™ื•ืช.
PubMed PMID: 20523044

๐Ÿ›๏ธ ื”ื›ืจื” ืฉืœ ื”-FDA Qualified Health Claim

ื‘ืฉื ืช 2003, ื”-FDA ื”ืืžืจื™ืงืื™ ื”ืขื ื™ืง ืœืคื•ืกืคื˜ื™ื“ื™ืœืกืจื™ืŸ ืž-SharpPSยฎ ืžืขืžื“ ืฉืœ Qualified Health Claim - ื”ื›ืจื” ืจืฉืžื™ืช ื‘ืงืฉืจ ื‘ื™ืŸ PS ืœื‘ื™ืŸ ื”ืคื—ืชืช ื”ืกื™ื›ื•ืŸ ืœื™ืจื™ื“ื” ืงื•ื’ื ื™ื˜ื™ื‘ื™ืช. ื–ื”ื• ืื—ื“ ืžืžืขื˜ ืชื•ืกืคื™ ื”ืชื–ื•ื ื” ืฉืงื™ื‘ืœื• ื”ื›ืจื” ื›ื–ื• ืžื”-FDA.

ืžื™ ืขืฉื•ื™ ืœื”ืคื™ืง ืชื•ืขืœืช ืž-SharpPSยฎ?

  • ๐Ÿง“ ืžื‘ื•ื’ืจื™ื ืžืขืœ ื’ื™ืœ 45 - ืœืชืžื™ื›ื” ื‘ื–ื™ื›ืจื•ืŸ ื•ื‘ื—ื“ื•ืช ื”ืžื—ืฉื‘ื”
  • ๐Ÿ“š ืกื˜ื•ื“ื ื˜ื™ื - ืœืฉื™ืคื•ืจ ืจื™ื›ื•ื– ื•ื–ื›ื™ืจืช ื—ื•ืžืจ ืœืคื ื™ ื‘ื—ื™ื ื•ืช
  • ๐Ÿ’ผ ืื ืฉื™ ืขืกืงื™ื - ืœื‘ื™ืฆื•ืขื™ื ืžื ื˜ืœื™ื™ื ื’ื‘ื•ื”ื™ื ืชื—ืช ืœื—ืฅ
  • ๐Ÿƒ ืกืคื•ืจื˜ืื™ื - ืžื—ืงืจื™ื ืžืจืื™ื ืชืžื™ื›ื” ื‘ืคื•ืงื•ืก ื•ื‘ื”ืชืื•ืฉืฉื•ืช ืžื ื˜ืœื™ืช

ืฉืืœื•ืช ื ืคื•ืฆื•ืช ืขืœ SharpPSยฎ

ืžื” ื”ื”ื‘ื“ืœ ื‘ื™ืŸ SharpPSยฎ ืœPS ืจื’ื™ืœ?

ืคื•ืกืคื˜ื™ื“ื™ืœืกืจื™ืŸ ื’ื ืจื™ ืžื™ื•ืฆืจ ืขืœ ื™ื“ื™ ืขืฉืจื•ืช ืกืคืงื™ื - ื‘ืขื™ืงืจ ื‘ืกื™ืŸ - ืœืœื ื‘ืงืจืช ืื™ื›ื•ืช ืื—ื™ื“ื” ื•ืœืœื ืžื—ืงืจื™ื ืงืœื™ื ื™ื™ื ื™ื™ืขื•ื“ื™ื™ื. ืจื™ื›ื•ื– ื”ื—ื•ืžืจ ื”ืคืขื™ืœ ื™ื›ื•ืœ ืœื”ืฉืชื ื•ืช ื‘ื™ืŸ ื™ืฆืจืŸ ืœื™ืฆืจืŸ, ืžื” ืฉื”ื•ืคืš ืืช ื”ืชื•ืฆืื•ืช ืœื‘ืœืชื™ ืฆืคื•ื™ื•ืช.

SharpPSยฎ ื”ื•ื ื”ืฆื•ืจื” ื”ืคื˜ื ื˜ื™ืช ืฉืœ ืคื•ืกืคื˜ื™ื“ื™ืœืกืจื™ืŸ, ืฉืคื•ืชื—ื” ืขืœ ื™ื“ื™ Enzymotec - ื—ื‘ืจื” ื‘ื™ื•ื˜ื›ื ื•ืœื•ื’ื™ืช ื™ืฉืจืืœื™ืช. ื‘ื ื™ื’ื•ื“ ืœ-PS ื’ื ืจื™, SharpPSยฎ ืžื™ื•ืฆืจ ื‘ืชื”ืœื™ืš ืžื‘ื•ืงืจ ื•ืžื•ื’ื“ืจ ื”ืžื‘ื˜ื™ื— ืžื™ื ื•ืŸ ืžื“ื•ื™ืง ืฉืœ 20% ื—ื•ืžืจ ืคืขื™ืœ ื‘ื›ืœ ื›ืžื•ืกื”. ื”ืžื—ืงืจื™ื ื”ืงืœื™ื ื™ื™ืื” ืฉื‘ื”ื ื”-FDA ื”ื›ื™ืจ ื‘-Qualified Health Claim ื‘ื•ืฆืขื• ืกืคืฆื™ืคื™ืช ืขืœ SharpPSยฎ - ืœื ืขืœ ืคื•ืกืคื˜ื™ื“ื™ืœืกืจื™ืŸ ื’ื ืจื™. ื›ืฉืžื•ืฆืจ ืฉืœ Harmony ืžืฆื™ื™ืŸ "ืžื›ื™ืœ SharpPSยฎ", ื”ืžืฉืžืขื•ืช ื”ื™ื ืื—ืช: ืื•ืชื• ืžืจื›ื™ื‘ ืฉื ื—ืงืจ, ืื•ืฉืจ ื•ืžื’ื•ื‘ื” - ืœื ืชื—ืœื™ืฃ ื–ื•ืœ.

ื›ืžื” ื–ืžืŸ ืœื•ืงื— ืœืจืื•ืช ืชื•ืฆืื•ืช?

ืžื—ืงืจื™ื ืขืœ SharpPSยฎ ืžืฆื‘ื™ืขื™ื ืขืœ ื˜ื•ื•ื— ืฉืœ 6โ€“12 ืฉื‘ื•ืขื•ืช ืฉืœ ืฉื™ืžื•ืฉ ืขืงื‘ื™. ื—ืœืง ืžื”ืžืฉืชืžืฉื™ื ืžื“ื•ื•ื—ื™ื ืขืœ ืฉื™ืคื•ืจ ื‘ืจื™ื›ื•ื– ื›ื‘ืจ ื‘ืฉื‘ื•ืขื•ืช ื”ืจืืฉื•ื ื™ื.

ืžื” ื”ืžื™ื ื•ืŸ ื”ืžื•ืžืœืฅ?

ื”ืžื™ื ื•ืŸ ืฉื ื—ืงืจ ื•ืื•ืฉืจ ื‘-FDA ื”ื•ื 300 ืž"ื’ ืœื™ื•ื, ื‘ื“ืจืš ื›ืœืœ ืžื—ื•ืœืง ืœ-3 ืžื ื•ืช ืฉืœ 100 ืž"ื’ ืขื ืืจื•ื—ื•ืช ื•ื‘ืžื™ื“ื” ื•ืžื“ื•ื‘ืจ ื‘SharpPS ืื– ื”ืžื™ื ื•ืŸ ื”ืžื•ืžืœืฅ ื”ื•ื 100-150 ืž"ื’ ื‘ื™ื•ื ืฉื ื™ืชืŸ ืœืžืฆื•ื ื‘ืžื•ืฆืจ ืฉืœื ื• Think


* ื”ืžื™ื“ืข ื‘ืืชืจ ื–ื” ื”ื•ื ืœืžื˜ืจื•ืช ืžื™ื“ืข ื‘ืœื‘ื“ ื•ืื™ื ื• ืžื”ื•ื•ื” ื™ื™ืขื•ืฅ ืจืคื•ืื™. ืชื•ืกืคื™ ืชื–ื•ื ื” ืื™ื ื ืชืจื•ืคื•ืช ื•ืื™ื ื ืžื™ื•ืขื“ื™ื ืœืื‘ื—ืŸ, ืœืจืคื ืื• ืœืžื ื•ืข ืžื—ืœื” ื›ืœืฉื”ื™. SharpPSยฎ ื”ื•ื ืกื™ืžืŸ ืžืกื—ืจื™ ืจืฉื•ื ืฉืœ Enzymotec Ltd.